Results 231 to 240 of about 8,691,348 (350)

Breast Cancer: Molecular Pathogenesis, Targeted Therapy, Screening, and Prevention

open access: yesMedComm, Volume 7, Issue 1, January 2026.
The review manuscript examines the molecular pathogenesis, screening, prevention advances, and evolving targeted therapies in breast cancer. It highlights the integration of AI and multiomics for precision prevention and personalized treatment, pointing toward future directions in equitable cancer care.
Huijun Lei   +7 more
wiley   +1 more source

Signaling pathways and targeted interventions for precancers. [PDF]

open access: yesSignal Transduct Target Ther
Yang J   +7 more
europepmc   +1 more source

[Laryngeal precancerous conditions].

open access: yesActa otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale, 1991
E A, Pallestrini   +3 more
openaire   +1 more source

Supernumerary chromosome 1 in interphase nuclei of atypical germ cells in paraffin-embedded human seminiferous tubules [PDF]

open access: yes, 1989
Bannwart, F.   +4 more
core  

Detection of Gastric Precancerous Conditions in Daily Clinical Practice: A Nationwide Survey

open access: yesHelicobacter, 2014
E. Lahner   +10 more
semanticscholar   +1 more source

Organoids in Cancer Research and Regenerative Medicine: Current Status, Challenges, and Future Prospects

open access: yesMedComm, Volume 7, Issue 1, January 2026.
The management of cancer and tissue regeneration remains a substantial challenge to global health. Organoids, which are stem cell‐derived three‐dimensional multicellular structures, are revolutionizing biomedical research. Therefore, this review highlights their applications in cancer research and regenerative medicine, while discussing current ...
Ruiyang Li   +5 more
wiley   +1 more source

Clinical Features and Treatment Strategies of Li‐Fraumeni Syndrome Patients With Inherited TP53 Mutations

open access: yesMolecular Genetics &Genomic Medicine, Volume 14, Issue 1, January 2026.
LFS with TP53 disease‐causing mutations may be potential beneficiaries of immune checkpoint inhibitors and targeted therapies. Therefore, NGS and PD‐L1 testing should be performed in all LFS patients. ABSTRACT Background Li‐Fraumeni syndrome is a rare autosomal dominant disorder caused by a pathogenic mutation of the tumor suppressor gene TP53.
Keyu Chen   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy